← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Owner-earnings 10-yr IRR 10–30 points over Treasuries, yield ≤ 25% · bought the day of the annual report, held 12 months
Could be luck Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +2.9 pts (823 entries, 255 companies, could be luck). 47% of entries beat the S&P; 18% beat it by 30 points or more; 27% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +1.2 pts.
+2.9 ptsvs S&P, average
47%beat the S&P
18%up 30+ pts vs S&P
27%down 20+ pts vs S&P
+6.0 ptsvs small caps, 12 mo
−14.6 pts 2024worst year to buy ?
1.8luck check ?
Does the holding period matter?3 mo: −0.5 pts 47% beat6 mo: +0.1 pts 45% beat12 mo: +2.9 pts 47% beat24 mo: +3.3 pts 42% beat3 yr, per yr: −0.9 pts 39% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today686+1.9 pts t 1.2+5.3 pts
Sell-off (S&P ≥10% off high)137+7.9 pts t 1.4+9.6 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing255+0.9 pts t 0.4−5.1 pts
Retail & consumer106+10.5 pts t 1.9+1.9 pts
Services79−3.2 pts t -0.5−1.9 pts
Energy69+3.1 pts t 0.5−4.9 pts
Other61−4.4 pts t -0.8−3.3 pts
Tech hardware & semis58−2.8 pts t -0.6−1.4 pts
Finance & real estate46+5.9 pts t 1.5+6.8 pts
Biotech & pharma28−5.0 pts t -0.7−4.3 pts

Holds up out of sample? Before 2018: +5.1 pts (n 291, t 2.3). From 2018: +1.7 pts (n 532, t 0.8). Same sign in both halves.

Year201120122013201420152016201720182019202020212022202320242025
vs S&P−11 pts+5 pts+6 pts−5 pts−4 pts+17 pts+8 pts−10 pts−14 pts+46 pts+8 pts+8 pts−14 pts−15 pts+3 pts
n12943515669425362725676876957

Read the research behind this screen: Ranking companies as equity bonds: the top fifth beats the bottom fifth by a wide margin → · Test your own combination in the Screen Lab →

Same definitions as the table: coupon = 3-yr average owner earnings, growth capped, 15× exit. Historical IRR uses a 5-yr revenue CAGR as the growth proxy where the DCF rate is not available point-in-time. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

CRANR
Crane Harbor Acquisition Corp. II
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRAQ
Cal Redwood Acquisition Corp.
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRAQR
Cal Redwood Acquisition Corp.
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRBD
Corebridge Financial, Inc.
Below Treasuries
Financial Services Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Below Treasuries
Healthcare Risk 35 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +58.1%/yr vs model +15.0% · above model
CRBU
Caribou Biosciences, Inc.
Below Treasuries
Healthcare Risk 46 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +64.6%/yr vs model +3.8% · above model
CRCL
Circle Internet Group, Inc.
Below Treasuries
Financial Services Risk 50 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +77.5%/yr vs model +50.0% · above model
CRDF
Cardiff Oncology, Inc.
Below Treasuries
Healthcare Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +77.6%/yr vs model +13.4% · above model
CRDL
Cardiol Therapeutics Inc.
Below Treasuries
Healthcare Risk 36 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRDO
Credo Technology Group Holding Ltd
Below Treasuries
Technology Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +49.4%/yr vs model +50.0% · in line
CREG
Smart Powerr Corp.
Below Treasuries
Technology Risk 41 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -50.0%/yr vs model +12.0% · below model
CRF
CORNERSTONE TOTAL RETURN FUND INC
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRGO
Freightos Ltd
Below Treasuries
Industrials Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRMD
CorMedix Inc.
Below Treasuries
Healthcare Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRML
Critical Metals Corp.
Below Treasuries
Basic Materials Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRNC
Cerence Inc.
Below Treasuries
Technology Risk 53 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +16.9%/yr vs model -3.5% · above model
CRNX
Crinetics Pharmaceuticals, Inc.
Below Treasuries
Healthcare Risk 36 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +71.6%/yr vs model +50.0% · above model
CRSP
CRISPR Therapeutics AG
Below Treasuries
Healthcare Risk 30 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +150.0%/yr vs model +2.0% · above model
CRT
CROSS TIMBERS ROYALTY TRUST
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRVO
CervoMed Inc.
Below Treasuries
Healthcare Risk 35 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +22.6%/yr vs model +15.0% · above model
CRVS
Corvus Pharmaceuticals, Inc.
Below Treasuries
Healthcare Risk 35 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRWD
CrowdStrike Holdings, Inc.
Below Treasuries
Technology Risk 45 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +9.1%/yr vs model +34.9% · below model
CSAN
Cosan S.A.
Below Treasuries
Consumer Cyclical Risk 36 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CSHR
CoinShares PLC
Below Treasuries
Financial Services Risk 60 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CSQ
CALAMOS STRATEGIC TOTAL RETURN FUND
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CSWC
CAPITAL SOUTHWEST CORP
Below Treasuries
Unknown Risk 45 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CTAA
Clearthink 1 Acquisition Corp.
Below Treasuries
Financial Services Risk 43 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CTAAR
Clearthink 1 Acquisition Corp.
Below Treasuries
Financial Services Risk 35 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CTGO
Contango Silver & Gold Inc.
Below Treasuries
Basic Materials Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +87.8%/yr vs model +5.0% · above model
CTMX
CytomX Therapeutics, Inc.
Below Treasuries
Healthcare Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +21.4%/yr vs model +19.5% · in line
CTNM
Contineum Therapeutics, Inc.
Below Treasuries
Healthcare Risk 47 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +18.4%/yr vs model +15.0% · above model
CTOR
CITIUS ONCOLOGY, INC.
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CTWO
COTWO ADVISORS PHYSICAL EUROPEAN CARBON ALLOWANCE TRUST
Below Treasuries
Financial Services Risk 28 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CTXR
Citius Pharmaceuticals, Inc.
Below Treasuries
Healthcare Risk 38 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +67.7%/yr vs model +15.0% · above model
CUB
Lionheart Holdings
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CUBWU
Lionheart Holdings
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CUE
Cue Biopharma, Inc.
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +92.7%/yr vs model +16.4% · above model
CUPR
Cuprina Holdings (Cayman) LTD
Below Treasuries
Healthcare Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +70.0%/yr vs model +15.0% · above model
CURR
Currenc Group Inc.
Below Treasuries
Technology Risk 34 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +18.5%/yr vs model -3.4% · above model
CURX
Curanex Pharmaceuticals Inc
Below Treasuries
Healthcare Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CV
CapsoVision, Inc
Below Treasuries
Healthcare Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +19.1%/yr vs model +15.3% · above model
CVE
CENOVUS ENERGY INC.
Below Treasuries
Energy Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CVKD
Cadrenal Therapeutics, Inc.
Below Treasuries
Healthcare Risk 34 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CVLT
COMMVAULT SYSTEMS INC
Equity-like
Technology Risk 45 · Elevated
Yield3.3%
Growth used12.9%
10-yr IRR7.8%
Grower · 5 yrs positive P/IV —
Market implies +23.6%/yr vs model +12.9% · above model
CVM
CEL SCI CORP
Below Treasuries
Healthcare Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CVV
CVD EQUIPMENT CORP
Below Treasuries
Industrials Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +55.0%/yr vs model +11.9% · above model
CWAN
Clearwater Analytics Holdings, Inc.
Below Treasuries
Technology Risk 39 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +35.9%/yr vs model +25.0% · above model
CWD
CaliberCos Inc.
Below Treasuries
Real Estate Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -20.9%/yr vs model +2.0% · below model
CWH
Camping World Holdings, Inc.
Below Treasuries
Consumer Cyclical
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CX
CEMEX SAB DE CV
Below Treasuries
Industrials Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CXAI
CXApp Inc.
Below Treasuries
Technology Risk 34 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +71.9%/yr vs model +15.0% · above model
CXE
MFS HIGH INCOME MUNICIPAL TRUST
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CXH
MFS INVESTMENT GRADE MUNICIPAL TRUST
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CXW
CoreCivic, Inc.
Below Treasuries
Financial Services Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CYAB
CYABRA, INC.
Below Treasuries
Technology Risk 35 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CYCN
Cyclerion Therapeutics, Inc.
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +106.6%/yr vs model +2.0% · above model
CYD
CHINA YUCHAI INTERNATIONAL LTD
Below Treasuries
Industrials Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CYN
Cyngn Inc.
Below Treasuries
Technology Risk 36 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +53.5%/yr vs model +15.0% · above model
CYPH
CYPHERPUNK TECHNOLOGIES INC.
Below Treasuries
Healthcare Risk 34 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +74.8%/yr vs model +15.0% · above model
CYRX
Cryoport, Inc.
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +47.6%/yr vs model +2.0% · above model